Literature DB >> 7829594

Improvement of hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. French Study Group for the Standardization of Hepatitis C Virus PCR.

.   

Abstract

Nine French laboratories, using the polymerase chain reaction (PCR) for detection of hepatitis C virus (HCV) RNA, initiated a quality control study to assess and to improve the specificity and sensitivity of their procedures. The study was carried out in three rounds, based on coded panels consisting of anti-HCV positive and anti-HCV negative samples. For the first panel, each laboratory followed its own protocol: 100% sensitivity was observed in two laboratories, 100% specificity in seven. For the second panel, all laboratories were required to use both their own procedure and a consensus procedure established from those laboratories which provided the best results on the first panel. With their own procedure, 100% sensitivity was observed in five laboratories and 100% specificity in all. With the common procedure, 100% sensitivity was observed in all but one, and 100% specificity in all. The third panel included three positive samples with four successive dilutions. For two samples, 8/8 laboratories had positive signals until the 1/100 dilution and discrepant results beyond this dilution; for the third sample, the signals were more discrepant. These results indicate that optimization and standardization of PCR may help laboratories to improve their procedure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7829594     DOI: 10.1016/0166-0934(94)90057-4

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Multicenter quality assessment of PCR methods for detection of enteroviruses.

Authors:  P Muir; A Ras; P E Klapper; G M Cleator; K Korn; C Aepinus; A Fomsgaard; P Palmer; A Samuelsson; A Tenorio; B Weissbrich; A M van Loon
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Multicenter trials need to use the same assay for hepatitis C virus viral load determination.

Authors:  Syria Laperche; Françoise Bouchardeau; Vincent Thibault; Bruno Pozzetto; Sophie Vallet; Arielle R Rosenberg; Anne-Marie Roque-Afonso; Michèle Gassin; Françoise Stoll-Keller; Pascale Trimoulet; Elyanne Gault; Bruno Chanzy; Bernard Mercier; Michel Branger; Jean-Michel Pawlotsky; Cécile Henquell; Françoise Lunel; Catherine Gaudy-Graffin; Sophie Alain; Marie-Laure Chaix; Gilles Duverlie; Jacques Izopet; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2007-10-03       Impact factor: 5.948

3.  Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.

Authors:  Ayaz M Majid; Heather Ezelle; Sangeeta Shah; Glen N Barber
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum.

Authors:  Pascale Trimoulet; Philippe Halfon; Eric Pohier; Hacène Khiri; Geneviève Chêne; Hervé Fleury
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum.

Authors:  Jean-Jacques Lefrère; Françoise Roudot-Thoraval; Françoise Lunel; Sophie Alain; Marie-Laure Chaix; Elisabeth Dussaix; Michèle Gassin; Jacques Izopet; Jean-Michel Pawlotsky; Christopher Payan; Françoise Stoll-Keller; Vincent Thibault; Mary-Anne Trabaud; Dominique Bettinger; Marc Bogard; Michel Branger; Claudine Buffet-Janvresse; Anne Charrois; Christine Defer; Catherine Laffont; Joëlle Lerable; Thierry Levayer; Michèle Martinot-Peignoux; Bernard Mercier; Arielle R Rosenberg
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.